Showing results (1-10 of 56) with videos related to
Sort By:
Pageof 6
Journal of Viral Hepatitis|February 26, 2019
Can we stop nucleoside analogues before HBsAg loss?Margarita Papatheodoridi, George PapatheodoridisCurrent Pharmaceutical Design|January 18, 2019
Diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD): Current ConceptsMargarita Papatheodoridi, Evangelos CholongitasCells|February 26, 2020
Emerging Diagnostic Tools to Decide When to Discontinue Nucleos(t)ide Analogues in Chronic Hepatitis BMargarita Papatheodoridi, George PapatheodoridisExpert Review of Anti-Infective Therapy|January 2, 2026
Nucleos(t)ide analogue treatment in hepatitis B: to stop or not to stop?Margarita Papatheodoridi, George PapatheodoridisLiver International : Official Journal of the International Association for the Study of the Liver|June 22, 2021
Is hepatitis delta underestimated?Margarita Papatheodoridi, George V PapatheodoridisExpert Opinion on Pharmacotherapy|November 4, 2022
State-of-the-art and emerging antivirals for chronic hepatitis B infectionMargarita Papatheodoridi, George V PapatheodoridisCurrent Opinion in Pharmacology|April 25, 2021
Current status of hepatitis deltaMargarita Papatheodoridi, George V PapatheodoridisDigestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 2, 2020
Regenerative hepatology: In the quest for a modern prometheus?Margarita Papatheodoridi, Giuseppe Mazza, Massimo PinzaniInternal and Emergency Medicine|May 30, 2020
Providing evidence on the ongoing health care workers' mask debateDimitrios Tsilingiris, Margarita Papatheodoridi, Chris J KapeliosLiver International : Official Journal of the International Association for the Study of the Liver|December 30, 2019
Clinical utility of hepatocellular carcinoma risk scores in chronic hepatitis BThodoris Voulgaris, Margarita Papatheodoridi, Pietro Lampertico, et al.Pageof 6